Literature DB >> 23490420

The effects of IL-17 upon human natural killer cells.

Suliman Al Omar1, Brian F Flanagan, Mazen Almehmadi, Stephen E Christmas.   

Abstract

These experiments were designed to investigate the effects of IL-17 upon the phenotype and function of human Natural Killer (NK) cells. Peripheral blood mononuclear cells from healthy subjects were cultured in the presence or absence of different combinations of IL-17s and changes in relative numbers and cell surface phenotype of NK cells and CD56+CD3+ cells measured by flow cytometry. Real time PCR was used to measure changes in expression of the cytotoxicity-related genes perforin A and granzymes A and B and IL-17 receptors. A chromium release assay was used to measure cytotoxic function against K562 tumour cells. IL-17D, IL-17A, IL-17F or the combination of both of the latter had little effect upon NK cell surface expression of Killer Immunoglobulin-like Receptors, although IL-17A modestly increased NK cell numbers. Slight but not significant increases in expression of perforin and granzymes were induced by IL-17A and/or IL-17F. Both IL-17A and D significantly increased cytotoxic function of NK cells at some E:T ratios. Similarly, numbers of NK cells induced to express CD107a after interaction with K562 cells were increased, but not significantly, by all combinations of IL-17s tested. IL-17RC was not found at the NK cell surface but was expressed at the message level and the protein detected intracellularly. NK cells are known to produce IL-17 but here we report that there is little response to this cytokine although some isoforms may moderately enhance cytotoxic function. There may therefore be some enhancement of NK cell function resulting from Th17 cell activation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23490420     DOI: 10.1016/j.cyto.2013.02.005

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  14 in total

1.  Interleukin-17 signaling mediates cytolytic natural killer cell activation in response to placental ischemia.

Authors:  Olivia K Travis; Dakota White; Cedar Baik; Chelsea Giachelli; Willie Thompson; Cassandra Stubbs; Mallory Greer; James P Lemon; Jan Michael Williams; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-22       Impact factor: 3.619

Review 2.  Inflammatory mediators: a causal link to hypertension during preeclampsia.

Authors:  Denise C Cornelius; Jesse Cottrell; Lorena M Amaral; Babbette LaMarca
Journal:  Br J Pharmacol       Date:  2018-09-28       Impact factor: 8.739

3.  Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy.

Authors:  Corbin A Shields; Maggie McCalmon; Tarek Ibrahim; Dakota L White; Jan M Williams; Babbette LaMarca; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-05-02       Impact factor: 3.619

4.  Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus Clearance.

Authors:  Dhiraj Acharya; Penghua Wang; Amber M Paul; Jianfeng Dai; David Gate; Jordan E Lowery; Dobrivoje S Stokic; A Arturo Leis; Richard A Flavell; Terrence Town; Erol Fikrig; Fengwei Bai
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

5.  Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure.

Authors:  Jamil Elfarra; Lorena M Amaral; Maggie McCalmon; Jeremy D Scott; Mark W Cunningham; Ashley Gnam; Tarek Ibrahim; Babbette LaMarca; Denise C Cornelius
Journal:  Clin Sci (Lond)       Date:  2017-11-23       Impact factor: 6.124

6.  Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells.

Authors:  M Bonacini; L Cimino; L De Simone; E Bolletta; F Gozzi; A Soriano; F Muratore; A Zerbini; L Fontana; C Salvarani; S Croci
Journal:  Clin Exp Immunol       Date:  2020-12-27       Impact factor: 5.732

Review 7.  Preeclampsia: long-term consequences for vascular health.

Authors:  Lorena M Amaral; Mark W Cunningham; Denise C Cornelius; Babbette LaMarca
Journal:  Vasc Health Risk Manag       Date:  2015-07-15

8.  Chronic infusion of interleukin-17 promotes hypertension, activation of cytolytic natural killer cells, and vascular dysfunction in pregnant rats.

Authors:  Olivia K Travis; Dakota White; W Austin Pierce; Ying Ge; Cassandra Y Stubbs; Frank T Spradley; Jan M Williams; Denise C Cornelius
Journal:  Physiol Rep       Date:  2019-04

Review 9.  Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy.

Authors:  Myriam Ben Khelil; Yann Godet; Syrine Abdeljaoued; Christophe Borg; Olivier Adotévi; Romain Loyon
Journal:  Cancers (Basel)       Date:  2022-01-05       Impact factor: 6.639

10.  The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24.

Authors:  Wai Po Chong; Mary J Mattapallil; Kumarkrishna Raychaudhuri; So Jin Bing; Sihan Wu; Yajie Zhong; WeiWei Wang; Zilin Chen; Phyllis B Silver; Yingyos Jittayasothorn; Chi-Chao Chan; Jun Chen; Reiko Horai; Rachel R Caspi
Journal:  Immunity       Date:  2020-07-15       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.